Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC54H49Cl2F6N7O8 |
InChIKeyZVQCWVLBPYOZNC-XNCCLBLBSA-N |
CAS Registry2306388-84-9 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Preclinical | China | 09 May 2019 | |
| Neoplasms | Preclinical | China | 09 May 2019 |





